Lawrence Carl
Lawrence Carl Panasci, Quebec CA
Patent application number | Description | Published |
---|---|---|
20110028422 | COMBINATION OF NILOTINIB AND A NITROGEN MUSTARD ANALOGUE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA - The invention relates to a combination which comprises (a) a DNA damaging agent; and (b) 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide (“nilotinib”); a pharmaceutical composition comprising such a combination and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment chronic lymphocytic leukemia (CLL); the use of such a combination for the preparation of a medicament for the treatment of CLL; a commercial package or product comprising such a combination; and to a method of treatment of a warm-blooded animal, especially a human. | 02-03-2011 |
Lawrence Carl Panasci, Dollard Des Ormeaux CA
Patent application number | Description | Published |
---|---|---|
20090312290 | COMBINATION OF A NITROGEN MUSTARD ANALOGUE AND IMATINIB FOR TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA - The invention relates to a combination which comprises (a) a nitrogen mustard analogue selected from chlorambucil, chlornaphazine, estramustine, mechlorethamine, mechlorethamine oxide hydrochloride, novembichin, phenesterine, prednimustine, trofosfamide or uracil mustard and (b) 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula | 12-17-2009 |
20150051236 | Combinations Useful for the Treatment of Chronic Lymphocytic Leukemia - The invention relates to a combination which comprises (a) a DNA damaging agent; and (b) 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidioyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide (“nilotinib”); a pharmaceutical composition comprising such a combination and optionally at least one pharmaceutical acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment chronic lymphocytic leukemia (CLL); the use of such a combination for the preparation of a medicament for the treatment of CLL; a commercial package or product comprising such a combination; and to a method of treatment of a warm-blooded animal, especially a human. | 02-19-2015 |
Lawrence Carl Spaete, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20080246632 | Aviation Rf Receiver Front End Multiplexing Method and Apparatus - A group multiplexed output ( | 10-09-2008 |
20080246670 | Aviation Application Setting Antenna Array Method and Apparatus - An antenna array ( | 10-09-2008 |
20080248772 | Integrated Aviation Rf Receiver Front End and Antenna Method and Apparatus - An aviation radio frequency receiver front end ( | 10-09-2008 |
Lawrence Carl Spaete, Jr., Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20110295445 | Method and Apparatus to Facilitate Providing a Synthetic View of Terrain for Use in a Moving Vehicle - Specific determinations are made in a moving vehicle ( | 12-01-2011 |